Login
$CSL
$345.97 +$0.93 (0.27%) Close

Consolidated Balance Sheets

In millions of USD; shares in millions, except per-share amounts
Q2 FY2026
As of Jun 30, 2026
Q1 FY2026
As of Mar 31, 2026
Q4 FY2025
As of Dec 31, 2025
Q3 FY2025
As of Sep 30, 2025
Q2 FY2025
As of Jun 30, 2025
Q1 FY2025
As of Mar 31, 2025
Q4 FY2024
As of Dec 31, 2024
Q3 FY2024
As of Sep 30, 2024
Q2 FY2024
As of Jun 30, 2024
Q1 FY2024
As of Mar 31, 2024
Q4 FY2023
As of Dec 31, 2023
Q3 FY2023
As of Sep 30, 2023
Q2 FY2023
As of Jun 30, 2023
Q1 FY2023
As of Mar 31, 2023
Q4 FY2022
As of Dec 31, 2022
Q3 FY2022
As of Sep 30, 2022
Q2 FY2022
As of Jun 30, 2022
Q1 FY2022
As of Mar 31, 2022
Q4 FY2021
As of Dec 31, 2021
Q3 FY2021
As of Sep 30, 2021
ASSETS
Cash and cash equivalents
Receivables, net of allowance for credit losses of $3.8 and $3.9
Inventories
Prepaid expenses
Other current assets
Assets held for sale
Total current assets
Property, plant, and equipment, net of accumulated depreciation of $800.5 and $774.0
Goodwill
Other intangible assets, net of accumulated amortization of $731.0 and $673.7
Other long-term assets
Total assets
LIABILITIES AND EQUITY
Accounts payable
Other current liabilities
Current portion of debt
Liabilities held for sale
Total current liabilities
Long-term debt
Contract liabilities
Deferred taxes
Other long-term liabilities
Total long-term liabilities
Preferred stock, $1 par value per share (5.0 shares authorized and unissued)
Common stock
Additional paid-in capital
Treasury stock
Accumulated other comprehensive loss
Retained earnings
Total stockholders' equity
Total liabilities and equity
Common stock, outstanding (in shares)

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support